Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Abbott Laboratories

DeJoy may have new conflict of interest

Justice Department urged to investigate after watchdog group found DeJoy owns stock in Abbott Laboratories

Here's How Much You Would Have Made Owning Abbott Laboratories Stock In The Last 10 Years

Here's How Much You Would Have Made Owning Abbott Laboratories Stock In The Last 10 Years

Abbott Laboratories (NYSE:ABT) has outperformed the market over the past 10 years by 2.51% on an annualized basis producing an average annual return of 15.1%. Currently, Abbott Laboratories has a market capitalization of $211.63 billion.

Abbott Laboratories Whale Trades For March 29

Abbott Laboratories Whale Trades For March 29

A whale with a lot of money to spend has taken a noticeably bearish stance on Abbott Laboratories. Looking at options history for Abbott Laboratories (NYSE:ABT) we detected 11 strange trades.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

FDA Inspection Flags Quality Control Issues At Abbott's Michigan Facility

An inspection at the Abbott Laboratories (NYSE: ABT) facility in Sturgis, Michigan,

Analyzing Abbott Laboratories's Short Interest

Abbott Laboratories's (NYSE:ABT) short percent of float has risen 15.69% since its last report. The company recently reported that it has 10.37 million shares sold short, which is 0.59% of all regular shares that are available for trading.

A Bearish Sign Appears On Abbott Laboratories's Chart

If history is any guide, there may be trouble ahead for shares of Abbott Laboratories (NYSE:ABT). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.

CNBC's Final Trades: Interactive Brokers, Abbott Laboratories, Apple And This REIT Stock

On CNBC’s “Halftime Report Final Trades,” Joseph Terranova of Virtus Investment Partners chose Interactive Brokers Group, Inc. (NASDAQ: IBKR) as his top pick.

inkl

Read news from The Economist, FT, and more,
with one subscription

Here's How Much $1000 Invested In Abbott Laboratories 10 Years Ago Would Be Worth Today

Here's How Much $1000 Invested In Abbott Laboratories 10 Years Ago Would Be Worth Today

Abbott Laboratories (NYSE:ABT) has outperformed the market over the past 10 years by 3.32% on an annualized basis.

Abbott facing lawsuits, FDA investigation over recalled infant formula after reports of illness, death

Parents who bought recalled infant formulas made by Abbott Laboratories are filing proposed class-action lawsuits against Abbott, as the U.S. Food and Drug Administration investigates reports of three babies who became sick and two who died after consuming the formulas.

Chicago Tribune

Abbott Recalls Baby Formula Manufactured At Michigan facility

Abbott Recalls Baby Formula Manufactured At Michigan facility

Abbott Laboratories (NYSE: ABT) recalls powdered baby formulas, including Similac, made at a Michigan facility after

3 Diabetes Stocks That are Better Investments Than Senseonics

3 Diabetes Stocks That are Better Investments Than Senseonics

Despite the ongoing global public health crisis, fundamentally-sound companies focused on diabetic treatments are seemingly unfazed. So, given Senseonics' (SENS) relative overvaluation and bleak growth prospects, we think it could be wise to bet on diabetes stocks Novo Nordisk (NVO), Eli Lilly (LLY), and Abbott Laboratories (ABT). Let’s discuss.

What 5 Analyst Ratings Have To Say About Abbott Laboratories

What 5 Analyst Ratings Have To Say About Abbott Laboratories

Over the past 3 months, 5 analysts have published their opinion on Abbott Laboratories (NYSE:ABT) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Abbott sold $2.1 billion worth of rapid COVID-19 tests in the last three months of 2021

As people across the country continue to grab at-home, COVID-19 tests off store shelves, Abbott Laboratories — the maker of one of the most popular of those tests — reported a stellar fourth quarter and financial year.

Chicago Tribune

Abbott Laboratories Whale Trades For January 26

Abbott Laboratories Whale Trades For January 26

Someone with a lot of money to spend has taken a bullish stance on Abbott Laboratories (NYSE:ABT). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Get all your
news in one place.

100's of premium titles.
One news app.

Abbott Posts $2.3B In COVID-19 Test Sales In Q4; Issues FY22 Outlook

Abbott Laboratories (NYSE: ABT) has reported

Recap: Abbott Laboratories Q4 Earnings

Abbott Laboratories (NYSE:ABT) reported its Q4 earnings results on Wednesday, January 26, 2022 at 07:30 AM. Here's what investors need to know about the announcement.

A Preview Of Abbott Laboratories's Earnings

Abbott Laboratories (NYSE:ABT) is set to give its latest quarterly earnings report on Wednesday, 2022-01-26. Here's what investors need to know before the announcement. Analysts estimate that Abbott Laboratories will likely report an Earnings Per Share (EPS) of $1.20.

CNBC's Final Trades: Abbott Laboratories, Starbucks, Bank of America And This Financial Services Stock

On CNBC’s “Halftime Report Final Trades,” Brenda Vingiello of Sand Hill Global Advisors named Abbott Laboratories (NYSE: ABT) as her pick.

Get all your
news in one place.

100's of premium titles.
One news app.

How Abbott Labs is crushing it in Asia

One secret to double-digit revenue growth: Low employee turnover.

1 … 5 6 7 8

People

189,724 stories

Brenda Vingiello

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Justice Department

Abbott Laboratories

U.S. Food and Drug Administration

inkl

Read news from The Economist, FT, and more,
with one subscription

Places

374,168 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play